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Mosquitoes are medically important arthropod vectors of arboviruses and 
Plasmodium parasites with half of the human population globally at risk of mosquito 
borne diseases. Due to the lack of efficient vaccines and the growing problem of 
insecticide resistance, alternative approaches to curb mosquito transmitted diseases are 
needed. An area of increased interest is the mosquito microbiome. Mosquitoes rely on 
microbes for larval development and the microbiome has also been shown to affect 
vector competence. In order to better understand the functions and effects of the 
microbiome, new tools must be developed to better target and investigate specific species 
of the mosquito microbiota. In this study, the potential use of bacteriophages as a tool to 
modulate the microbiota composition in Aedes aegypti larval breeding water was 
investigated. Mosquito larvae were placed in gnotobiotic conditions where different 
bacteria species were inoculated into the breeding water to study the effect that 
bacteriophage-mediated modulation of the microbiota had on time to pupation. Six 
bacteria species were used: E. coli W3110, Enterobacter spp., Serratia spp., two 
Microbacterium species, and Arthrobacter spp.. Larval development was first observed 
when only one of the six bacteria species was added to the breeding water and it was 
shown that in the E. coli W3110 and Enterobacter spp. treatments, larvae reached 
pupation the fastest with the highest survival rate of the six species. The two 
Microbacterium species mediated the slowest pupation rates and the lowest survival 
rates. The E. coli-infecting bacteriophage, T7, was then added to the breeding water in a 
separate E. coli treatment as a bacteria-bacteriophage proof of concept. Delays in larval 
pupation and lower survival rates were then observed in the bacteriophage treatment. 
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Bacteriophages targeting Enterobacter spp. and Serratia spp. were then isolated and the 
Enterobacter spp. were sequenced. Sequencing revealed that the two isolated 
bacteriophages were induced from two prophage regions of the Enterobacter spp. 
genome. 
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Vector-borne diseases account for about 17% of the global burden of all 
infectious diseases. Attempts to treat and prevent infection is a heavily researched area 
with various levels of success. One of the most successful interventions has been to 
control the vectors, mostly through various pesticide uses. However, due to the long use 
of these pesticides, an increasing number of mosquito populations have been gaining 
resistance to these pesticides and new interventions to control mosquito populations must 
be sought (Liu 2016).  
 
Malaria 
The Anopheles mosquito is the primary mosquito vector responsible for the 
transmission of malaria in most of sub-Saharan Africa. Of the 400 different species, 
about 30 are malaria vectors of high importance (WHO 2019). Of those 30, A. darlingi 
(South America), A. gambiae s.s., A. funestus (sub-Saharan Africa), and A. culicifacies 
(South Asia) are considered the dominant malaria vectors in their geographic area 




Figure 1: Global distribution of dominant or potentially important malaria-transmitting 
Anopheles species (Kiszewski et al. 2004) 
Though most Anopheles do not have a preference between blood-feeding on 
humans or other animals, A. gambiae and A. funestus are two species that do show a 
strong preference for humans, thus are two of the most efficient malaria vectors (WHO 
2018). As seen in Figure 1, Anophelse species that can transmit malaria are found 
worldwide, and even if a region had eliminated malaria or if it is not endemic to the area, 
there is still a risk of introduction or re-introduction. 
Malaria is caused by the Plasmodium protozoan parasite, of which there are five 
species that cause malaria in humans. P. falciparum and P. vivax are two of those species 
that are the most cause for concern. In 2017, P. falciparum accounted for 99.7% of 
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malaria cases in the African region. P. vivax accounted for 74.1% of malaria cases in the 
Americas (WHO 2019). 
Plasmodium has two lifecycles, one in the mosquito, the other in the human host. 
There are some differences in the lifecycle depending on the Plasmodium species, but all 
still follow a similar pattern. When a human host is bitten by a mosquito that is infected 
with the parasite, the sporozoite stage enters the human bloodstream from the mosquito 
salivary glands and will travel to the liver to infect the hepatocytes cells. Once in the 
liver, the sporozoites develop asexually into exoerythrocytic merozoites over the course 
of 5-15 days. P. vivax, P. ovale and P. cynomolgi have a dormant stage where 
hypnozoites do not mature and may stay in the liver for months or even years before the 
parasite develops into exoerythrocytic schizogony like other Plasmodium species that 
then release merozoites into the bloodstream. Merozoites infect red blood cells and 
develop into trophozoites in the erythrocytic cycle. The trophozoites develop into 
schizonts, which rupture to release more merozoites. The merozoites can also enter a 
sexual differentiation stage and develop into gametocytes. It is the gametocytes that are 
taken up by a mosquito in a bloodmeal.  
Once in the mosquito, the parasitic gametocytes move through the mosquito 
digestive tract with the blood meal and sexually reproduce in the mosquito gut within 
minutes of taking the bloodmeal. The resulting zygotes develop into ookinetes that are 
mobile and move to penetrate the peritrophic matrix 24-36 hours later. After penetrating 
the matrix, the ookinete continue to move through the midgut epithelium. Once the 
ookinetes reach the basal side of the epithelium, they develop into oocysts that develop 
under the basal lamina of the midgut to develop and mature for about 10-12 days. The 
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oocysts then release sporozoites numbering in the thousands that travel throughout the 
mosquito’s body through the hemolymph, infecting cells throughout the mosquito body. 
It is only when the sporozoites travel to and infect the mosquito’s salivary glands that the 
entire infectious lifecycle is able to start over again. (CDC 2018, Mikolajczak et al. 2015, 
Wahlgren & Perlmann 1999, Luckhart et al. 1998). 
The first symptoms of malaria are nonspecific and include fever, headache, chills, 
dizziness, and abdominal pain. Severe malaria symptoms are more important to take note 
of, but are similarly nonspecific and include confusion, coma, severe anemia, or 
respiratory difficulties (CDC 2018). Cases can only be confirmed with a laboratory test. 
Laboratory tests can be done with microscope diagnosis, the gold standard, where the 
patient’s blood is spread in a blood smear and parasites can be visually identified. 
Antigen detection is another test, also known as the Rapid Detection Test as they provide 
results in a matter of minutes and are much more readily available (CDC 2018). 
Though recent interventions have been quite successful at halving the malaria 
burden in Africa since 2000, in 2017, 219 million cases of malaria were still reported. 
The number of malaria deaths stood at 435,000 (WHO 2019) and malaria still has an 
economic burden of $12 billion dollars annually worldwide (CDC 2018). 
 
Dengue 
Aedes aegypti is another mosquito of high public health importance. A. aegypti is 
the primary vector of many viral diseases such as yellow-fever, Chikungunya, and 
dengue fever (Aitken et al. 1979, Lamballerie et al. 2008, Weaver & Reisen 2010). The 
mosquito is found worldwide, though originally evolved in West Africa. Its ecological 
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success has been due to globalization, widespread colonization, increased human 
populations, and cross-oceanic travels (Weaver & Reisen 2010). It thrives in dense 
human populated areas with limited water and sanitation infrastructure (Honório et al. 
2009). A. aegypti’s preference for dense populations along with various other behaviors 
make it a very efficient epidemic vector. Not only are A. aegypti able to breed in close 
proximity to human through the use of collected water in old tires, trash, cement cisterns, 
and open septic tanks, they are also able to rest indoors and bite during daylight hours. 
There are two peaks times of biting, one for a few hours after sunrise and another several 
hours before sunset (Gubler 1998). A. aegypti females will also feed on multiple people 
for one blood meal. They will stop feeding if only slightly disturbed and then return to 
feed on the same or different person. This allows them to even transmit diseases if they 
probe at a person even without taking a full blood meal (Platt et al. 1997). A. aegypti is 
restricted to temperate zones as their eggs do not undergo winter diapause and are 
vulnerable to frost (ECDC 2016). 
Dengue fever is caused by a single stranded RNA virus belonging to the 
Flaviviridae family and is the most common arboviral and vector-borne disease in the 
world. In order to infect a host cell, a Dengue virion must first bind to cell-surface 
attachment molecules and receptors after which the virion is internalized into the host cell 
through endocytosis. The viral glycoproteins can then mediate a fusion of the viral and 
host cell membranes due to the low pH of the endosome. Once the viral and host cell 
membranes have fused, the viral RNA can be released into the host cell cytoplasm. The 
vRNA is then processed by viral and cellular proteases and the resulting non-structural 
proteins replicate the viral genome RNA. The virus assembly happens at the endoplasmic 
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reticulum membrane to form immature virus particles. As these virus particles are 
transported through the host cell, they pass through the trans-Golgi network where the 
acidic environment promotes virus maturation. The mature virus is then released from the 
cell (Bäck & Lundkvist 2013). 
When a mosquito takes an infected blood meal, the first host cells the Dengue 
virion must infect in the mosquito are the midgut epithelial cells. From there, the virus 
particles are then released into the hemolymph where they continue to spread throughout 
the mosquito body and infect other host cells. The virus must then spread and infect the 
mosquito salivary glands in order to continue to transmit the disease when it takes its next 
blood meal (Xi et al. 2008). The extrinsic incubation time of the Dengue virus in the 
mosquito is about 7-14 days, though the highest levels of virus titer in the salivary glands 
happens at about 12-18 days. This is the period that a mosquito is able to spread the 
disease most effectively and quickly (Salazar et al. 2006). 
Dengue has been recorded as far back as the Jin Dynasty (265 to 420 CE) where a 
published Chinese encyclopedia described symptoms of and remedies for dengue 
(Nobuchi 1979).There are four recognized serotypes of dengue, DEN-1, DEN-2, DEN-3, 
and DEN-4, all have been isolated from field-collected A. aegypti (Gratz 2004). Recovery 
from one serotype provides lifelong immunity against only that serotype. Cross-immunity 
to the other serotypes does occur after recovery but is only partial and temporary. 
Subsequent infections by other serotypes increases the risk of developing severe dengue 
infections (Deen et al. 2006).  
The general form of the infection produces nonspecific flu like symptoms such as 
fever, frontal headache, nausea and vomiting, weakness, and rash (Waterman et al 1989). 
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Dengue hemorrhagic fever (DHF) is much more serious and is most common in children 
under the age of 15 years. During the beginning stage of DHF, the symptoms match 
dengue fever making it difficult to determine a clinical diagnosis. However, with DHF, 
there is an increase in vascular permeability which leads to plasma leakage. About 24-28 
hours after the initial fever starts to decrease, patients may exhibit severe abdominal pain, 
persistent vomiting, rapid breathing and bleeding gums (WHO 2014). Without 
appropriate treatment and support, patients can go into hypovolemic shock and risk death 
(Gubler 1998). All four serotypes have been associated with DHF and variations between 
the serotypes only have influence on disease severity (Gubler 1998).  
Dengue has an economic burden of $1.8 billion annually worldwide (Suaya et al 
2009) and there are 50-100 million cases reported annually (Gibbons & Vaughn 2002). 
The global pandemic began after World War 2 when Southeast Asia saw huge increases 
in global transmission due to the Pacific theater (Halstead 1980, Gubler & Trent 1993) 
and later intensified in the 1980s (Halstead 1992, Pinheiro & Corber 1997). Dengue 
infection was rare outside of Southeast Asia previous to the 1940’s, but by the 1980s 
DHF was on the rise worldwide regardless if the region had no endemic dengue, one 




Figure 2: DENV co-circulation. As the key color becomes more saturated, the total 
number of reported DENV serotypes increases, a key indicator of hyperendemic 
transmission (Messina et al, 2014) 
 
Prevention and Control 
Malaria vaccine development started in the 1960’s, but it has been proven 
difficult to develop a vaccine that confers long lasting immunity after one or a few 
exposures. The first report of a successful malaria vaccination happened in 1973, 
volunteers were immunized through the bites of about 1000 irradiated mosquitoes that 
had also been infected with Plasmodium sporozoites (Clyde et al. 1973). As interesting as 
this finding was, it became clear that vaccination through mosquito bites was not going to 
be a feasible disease control intervention.  
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Some of the reasons for difficulty of developing a malaria vaccine are the size and 
plasticity of the Plasmodium genome, the large variation of blood-stage antigens, and the 
need to ensure the vaccine does not set off a host immune response. The Plasmodium 
genome has about 23 million DNA base pairs, 14 chromosomes and has about 5,000 
genes (Gardner et al. 2002). This genome is much larger than any of the bacteria or 
viruses that successful vaccines have been made for. Various genes are differentially 
expressed between the different life stages and their functions are not well understood. 
Plasmodium undergoes sexual reproduction and genetic recombination all of which lead 
to increased diversity and complexity of the Plasmodium parasites that make developing 
a single vaccine difficult. This is the same problem with blood-stage antigen diversity. In 
a single African village, there were over 200 recorded variants on one leading blood stage 
antigen (Takala et al. 2009). Without more careful molecular epidemiologic studies, 
simply choosing a few genetic variants to be used in a vaccine make it unlikely the 
vaccine would be cross-protective. 
And like all other illnesses, the immune response to malaria contributes to the 
development of symptoms. Without careful diligence, a vaccine could increase the risk of 
a harmful inflammatory response especially with a vaccine targeting the blood stages. 
While there are several antimalarial drugs for therapeutic use, Plasmodium is notorious in 
developing drug resistance, thereby rendering the use of drugs for malaria elimination 
less effective. 
Attempts to develop a dengue vaccine started since the viruses were first isolated 
in the 1940s (Sabin & Schlesinger 1945) and only recently has a dengue vaccine been 
approved for dissemination in the US (FDA 2019). This vaccine, Dengvaxia, however, 
10 
 
has only been approved for people who have already been infected with at least once. 
This is due to the vaccine was suspected of putting naïve populations at higher risk of 
severe infections (WHO 2017). There are also no therapeutic treatments for dengue. If an 
individual is infected and showing serious symptoms, the standard of care is only to keep 
monitoring the patient and providing supportive care. Some of the obstacles in 
developing a dengue vaccine for naïve populations have been the lack of an animal model 
and the necessity for a tetravalent vaccine. As mentioned previously, if a patient has 
preexisting antibodies to a different serotype than the one they are infected with, there is 
an increase in the risk of developing DHF (Sangkawibha et al. 1984, Burke et al. 1988). 
However, new studies and developments in vaccines have shown promise. At the Johns 
Hopkins Bloomberg School of Public Health, Dr. Anna Durbin led a clinical trial that 
demonstrated that a live attenuated vaccine elicited complete protection against DENV-2. 
Previous clinical trials showed the vaccine, TV003, elicited strong protection against 
DNV-1, 2, and 4. Since the findings of DENV-2 protection were released, Brazilian 
researchers began a Phase 3 clinical trial to investigate the vaccine’s response and 
efficacy against naturally occurring dengue (Kirkpatrick et al. 2016).  
With slow development in controlling vector-borne disease from the human side, 
vector population control has been one of the key interventions in reducing disease 
incidence. DDT was one of the first chemical vector-controls and was used extensively in 
the 1940s (Hemingway et al. 2002). The success of DDT’s use and elimination of malaria 
in the USA led to the WHO’s malaria eradication campaign in the 1960’s. While DDT’s 
use has been scaled back in the last few decades, new insecticides have been discovered 
and used. Pyrethroids are adulticides and were introduced for widespread use in the 
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1980s (Zaim & Guillet 2002). They are one of the most common insecticides used today. 
They are used for control methods such as bed nets and indoor residual house spraying 
and are popular due to low toxicity in humans and their effectiveness in killing insects 
(Hougard et al. 2002).  
However, due to their prolific use, insecticide resistance is on the rise. Pyrethroid-
resistant A. gambiae populations are prevalent in western and central Africa (Ranson et 
al. 2011).  
It is thought there are two major mechanisms that are responsible for insecticide 
resistance; target site resistance and metabolic resistance. Target site resistance has been 
better researched and understood; pyrethroids delay the closing of sodium channel in 
insect neurons leading to paralysis and death (Ridl et al. 2008, Davies et al. 2008). 
Changes and mutations to that target site are what cause insecticide resistance. Metabolic 
resistance happens when one or more enzymes become more active and either sequester 
or detoxify an insecticide and thereby lowering its effectiveness. Metabolic resistance has 
not been as well studied, but some key enzymes have been identified in insecticide 
detoxification. Cytochrome P450 is a primary enzyme family identified in metabolic 
resistance (Feyereisen 2005). As more enzyme families that appear to play a role in 
metabolic resistance are discovered, there is the possibility of the discovering molecular 
markers for metabolic resistance. This would help in determining how metabolic 





Figure 3: Changes in pyrethroid mortality in major African malaria vectors. Percentage 
mortality of (A) Anopheles gambiae sensu lato (s.l.) and (B) Anopheles funestus s.l 
mosquitoes exposed to 0.05% deltamethrin (blue) or 0.75% permethrin (orange) in 
World Health Organization (WHO) susceptibility bioassays (Ranson & Lissenden 2016) 
 
Mosquito Lifecycle  
Mosquitoes are part of the order Diptera, family Culicidae. Like all other Diptera, 
mosquitoes go through a complete metamorphosis and have four stages in their life cycle: 




Figure 4: Mosquito lifecycle (Vector Disease Control International) 
All mosquitoes require standing water to lay their eggs, though whether they lay 
in “floodwater” environments (temporary water habitats) or “permanent water” 
environments depends on the species. They lay their eggs directly on the water, some 
species lay their eggs in rafts, others lay their eggs individually.  Eggs take a few days to 
hatch, though some can undergo diapause and overwinter as eggs. Once hatched, larvae 
will filter feed on microorganisms and organic material in the water; as they grow, they 
will go through 4 instars, or molts. Going through all instars can take about a week, 
though exact timing depends on the species and environment. After the fourth instar, the 
larvae will molt into a pupa. Known colloquially as “tumblers” due to their tumbling 
movement in the water, these pupae do not feed and will stay as a pupa for a few days as 
the mosquito metamorphosizes within. Adults will emerge from the pupa and fly off from 
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the water environment, many mating soon after. Both male and female mosquitoes will 
feed on plant nectars, but females are the only ones that will take a bloodmeal as it is 
necessary for egg development. Once the bloodmeal has been digested and the eggs have 
formed, the female mosquito will lay the eggs on a water surface, completing the 
lifecycle (Vector Disease Control International, CDC 2019). 
 
Mosquito Microbiome 
 As with any animal, recent research has shown the importance of the mosquito 
microbiota for a variety of processes. The microbiota is necessary for larval development 
and pupation and can influence the vector competence of the adult mosquito.   
Mosquito adults and larvae occupy two completely different environments with 
the larvae and pupae living in aquatic environments and adults occupying terrestrial 
environments, the composition of the gut microbiota between the two stages is also 
different. This is exacerbated by the fact that mosquito larvae flush out their microbiome 
as they pupate allowing a new community of microbes to colonize the adult mosquito’s 
gut.  
Mosquito larval acquire endogenous bacteria through various mediums. Most 
commonly is through the breeding water that they hatch into. As the larva filter feed in 
their environment, they also take in the bacteria present (Minard et al. 2013). Because the 
gut microbiome is so dependent on the surrounding environment, different studies tend to 
find different compositions in microbial communities. Yadav et al. (2015) surveyed wild 
mosquitoes in India and found that the most common bacteria found in the larval gut of 
Aedes aegypti and Aedes albopictus were the families Enterobacteriaceae, Bacillaceae, 
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and Pseudomonadaceae. Coon et al. (2014) performed studies with lab reared mosquitoes 
and found that in A. aegypti and An. gambiae, the most common bacteria found were 
Flavobacteriaceae and Microbacteriacea. Female mosquitoes can also pass down certain 
bacteria and fungi to their offspring through vertical transmission. This vertical 
transmission usually occurs through an infection of the egg cytoplasm (Sinkins 2004), 
colonization of the egg surface (Damiani et al. 2010), or through inoculating the breeding 
water (Lindh 2008). 
Coon et al. (2014) also showed that bacteria are necessary in the larval stage for 
development. The bacteria in the gut gradually create a hypoxic environment, once the 
hypoxia reaches a certain level, it triggers a molting response in the larva and thus, 
progresses the development. However, despite the knowledge that a bacterial community 
is required for larval development, it is still unknown if each separate species of bacteria 
have different functions or effects on the mosquito. 
Understanding the adult and larval mosquito microbiome has become a growing 
field of interest. Several studies have shown that changing the adult microbiota can affect 
vector competence. Dong et al. (2009) showed that a subset of immune genes were 
upregulated in septic adult Anopheles gambiae mosquitoes compared to aseptic 
mosquitoes. They also found that septic mosquitoes were less susceptible to Plasmodium 
infection as compared to the aseptic mosquitoes, thus suggesting that the anti-
Plasmodium effect may be due to that upregulation of immune genes. 
 
Mosquito Midgut Microbiome Composition 
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 We are focusing on four different bacteria genera that have been consistently 
found in mosquito midgut microbiome. We looked at Enterobacter spp., Serratia spp,, 

















(Kim et al. 
2015) 
(Kim et al. 
2015) [18,20,69] [39,68] [39] 
Enterobacter + + + - + - 
Serratia - + - + - + 
Arthrobacter - - - + - - 
Microbacterium + + - + + - 
Table 1: List of bacteria found in mosquito larvae (Guégan et al. 2018) 
 
Enterobacter 
Enterobacter is a commonly found bacteria genus in both the adult and larvae 
mosquito and in various mosquito species. Kim et al (2015) found Enterobacter in two 
different Aedes species larvae. They sampled two sites in rural Illinois, USA and looked 
at three different mosquito species. They collected water samples, fourth instar larvae, 
and pupa. Larvae were speciated through morphology and then dissected. The pupa were 
allowed to continue to develop and the emerged adult was also speciated by morphology 
and then dissected. They did show that the abundance of higher bacteria taxa was similar 
between the water samples and the larval gut microbiome as that there were significant 
differences between larval and adult midgut compositions. In total they found 57 
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culturable bacteria species between all water and mosquito samples. Enterobacter was 
also found in a Culex species.  
Along with being a commonly found bacteria, there has also been evidence that 
Enterobacter specifically can play a role in vector competence, specifically inhibiting 
Plasmodium infection. Eappen et al (2013) found that AsSRPN6, an A. stephensi putative 
serine protease inhibitor is differentially induced by different bacteria. AsSRPN6 had 
been previously found to be expressed when midget cells had been infected by 
Plasmodium (Abraham et al. 2005). Eappen et al. found that AsSRPN6 was strongly 
expressed when exposed to gram-negative bacteria, whereas gram-positive bacteria 
elicited a weaker response. Cirimotich et al. (2011) that the Enterobacter species Esp_Z 
was able to inhibit the development of Plasmodium ookinetes without negatively 
affecting the mosquito fitness. 
 
Serratia 
Serratia has also been found to increase mosquitoes’ susceptibility to dengue. 
Serratia odorifera specifically has been shown to enhance DENV-2 in A. aegypti. When 
S. odorifera was introduced to antibiotic treated A. aegypti, they showed a significant 
increase in their susceptibility to DENV-2 compared to a group of mosquitoes that did 
not receive additional bacteria and compared to a group that received a different bacteria 
species. 
Serratia marcescens has been of particular interest due to its insecticidal effects. 
Prodigiosin is a metabolite alkaloid known for its bright red color. Its produced by the 
strain S. marcescens NMCC46. Patil et al. (2011) tested prodigiosin for larvicidal effects. 
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Testing it against A. aegypti and A. stephensi, they found that the mortality rate for all 
four instars positively increased with increasing dosage of prodigiosin. S. marcescens has 
also been found to limit Plasmodium infection in mosquitoes. Two A. stephensi treatment 
groups were challenged with P. berghei, one that had been cleared with antibiotics, 
another that had not. The group that had been cleared had a much higher infection rate. 
When S. marcescens was reintroduced to the cleared A. stephensi, it was able to inhibit P. 
berghei, but only when the mosquitoes were able to continuously feed on a S. marcescens 
solution as the mosquitoes cleared S. marcescens from their gut within three days (Bando 
et al. 2013). 
  
Arthrobacter 
The Arthrobacter genus are gram-stain-positive coryneform bacteria that have 
been found in a wide variety of environments. It is most commonly found in soils in 
different parts of the world. This genus is resistant to drying and starvation making it well 
adapted to soil environments, though their numbers decrease with increased soil acidity 
(Jones & Keddie 2006). Arthrobacter can also be found a range of insects. İnce et al. 
(2014) reported to isolate the species Arthrobacter pityocampae strain Tp2T from the pine 
processionary moth, Thaumetopoea pityocampa, a moth considered one of the most 
harmful pests of pine species in the Mediterranean. Moro et al. (2012) identified 





Microbacterium is part of the family Microbacteriaceae, a group of gram-positive 
primarily soil bacteria. Microbacterium itself has been isolated from various mosquitoes. 
Kim et al. (2015) were able to identify Microbacterium from unspeciated mosquito larvae 
sampled from rural Illinois. 
Coon et al 2016 found that gnotobiotic reared A. aegypti and A. atropalpus that 
had been inoculated with Microbacterium all died as first instars. Similarly, in Coon 
2016, the researchers attempted to rescue the development of axenic larvae by 
inoculating the breeding water with one type of bacteria. Of the seven different species, 
larvae inoculated with Microbacterium were one of two treatments that did not recover 
after it was added to the first instar larvae. 
  
Bacteriophages 
Bacteriophages are viruses that only infect bacteria. They play an important role 
in the evolution of functional and taxonomic diversity of the targeted host bacteria 
species through cell lysis, phage-bacterial co-evolution, and horizontal-gene transfer 
(Jasna et al. 2017, Touchon et al. 2017, Zeng et al. 2017, Paterson et al. 2010). This 
comes from two key factors in the bacteriophage life cycle. One is the bacteriophages’ 
high specificity in infection. Most bacteriophages are so specialized that they can only 
target one species or one strain of bacteria. The second key factor is that bacteriophages 
have two distinct life cycles, a lytic and a lysogenic cycle. The lytic phase infects the 
bacteria cells, reproduces, and then lyses the cell to escape and continue propagation. In 
the lysogenic phase, the bacteriophage infects the bacteria cell, but then the 
bacteriophage’s genetic material integrates into the bacteria’s genome. Once integrated, 
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the bacteriophage “reproduces” and replicates as the bacteria replicates. Bacteriophages 
can be found almost anywhere bacteria are found (Wommack & Colwell, 2000). In recent 
years, bacteriophages have seen an increase in mainstream, clinical relevance as a 
potential solution to the rising problem of antibiotic resistant bacteria through the use of 
phage therapy, as a tool in food safety, and as a control in agriculture.  
 
 
Figure 5: The bacteriophage lytic and lysogenic lifecycle (Doss et al. 2017) 
 
Use of Bacteriophages in Humans 
 The first clear description of bacteriophages come from a French-Canadian 
scientist, Felix d’Herelle (d’Herelle 1917). What he observed were plaques forming from 
samples of filtered stool derived from dysentery patients. While initially searching for a 
possible virus cofactor in dysentery infection, d’Herelle found that the plaques, or the 
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bacteriophages, increased in titer as the disease progressed and were highest during 
recovery. He then inferred that there was “an exogenous agent of immunity” that assisted 
with recovery (Summers 2001). With this discovery, phage therapy was first applied to 
farm animals such as chickens and pigs to treat their infections. By the 1920s phage 
therapy had extended to human trials. The biggest breakthrough to the mainstream 
occurred when d’Herelle treated 4 patients infected with the bubonic plaque with a 
bacteriophage preparation and all 4 recovered quickly (d’Herelle 1926). 
However, as standards started changing in the 1930s so did scrutiny for 
bacteriophage treatments and preparations. The actual biological nature of bacteriophages 
was still poorly understood; how did they clear the bacteria, how did they replicate, was 
there possibility for human infection; and there was no standard for potency or purity of 
the bacteriophage preparations. These two main factors made it difficult to assess 
bacteriophage treatments as different councils and associations attempted to standardize 
the pharmaceutical field (Summers 2001). Additionally, broad spectrum antibiotics began 
to pick up in popularity. Manufacturing became easier and these treatments were much 
more stable and easier to measure, both with regards to the results and the preparation. 
However, phage therapy has continued to be a field of research and treatment in 
eastern Europe. This may have partly been due to the fact that in the 1930’s, the Soviet 
Union was at war with the Finns, and phage therapy was used to treat the wounded. 
Regardless of the historical reasons why phage therapy was never eclipsed by antibiotics 
in eastern Europe, phage therapies still remain a common and viable treatment there 
(Sulakvelidze et al. 2001, Summers 2001). 
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Recently, it has elicited interest the western world (Levin & Bull 2004). The 
increased risk and development of antibiotic-resistant pathogenic bacteria has pushed 
western scientists to look for alternative solutions (Burnham et al. 2018). As incidences 
of “superbug” infections continue to rise, the phage therapy treatments have begun to 
reach media headlines and have reignited interest in bacteriophages (Herschler 2016, 
Molteni 2019). 
The phage-mediated therapeutic approach is currently a slow process. 
Bacteriophages have to be identified one by one in order to combat antibiotic-resistant 
bacteria. Most are found through screening processes sampling sewage water and other 
bacteria rich environments. Furthermore, for phage therapy to be effective or even work 
at all, the bacteriophages must be highly lytic. Instead of integrating into the bacteria 
genome, once the bacteriophage has infected the bacteria, it must start to reproduce and 
lyse the bacteria cells quickly. The more virulent the bacteriophage is and the more 
quickly it is able to reproduce, the more effective the treatment will be. 
Additionally, bacteriophages have seen potential as antibody delivery and as 
diagnostic tools. Bacteriophages can be used to directly vaccinate if the bacteriophages 
are carrying the antigens on the surface of their coat or the bacteriophage can be used to 
deliver a DNA vaccine expression cassette that has been integrated into the 
bacteriophage’s genome (Clark & March 2014). High specificity of bacteriophage 
infection of the host and inability to infect eukaryotic cells make them an ideal tool for 
selectively modifying any microbiota. 
 
Use of Bacteriophages in Agriculture 
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Just like with human phage therapy, deliberate use of bacteriophages in 
agriculture goes back to the beginning of the 1900’s. Mallman and Hamstreet observed in 
1924 that filtering the liquid obtained from rotting cabbages and then applying it to 
growing fields of cabbages, it inhibited the growth of Xanthomonas campestris pv 
campestris, the bacterium that causes the rot. After that, numerous other scientists 
isolated bacteriophages to combat a number of plant pathogens, including 
Pectobacterium carotovorum subsp atrosepticum, the cause of the potato disease, 
blackleg disease (Kotila & Coons 1925); Pantoea stewartia, a bacterium that infects corn 
seeds (Thomas 1935); and Xanthomonas pruni, a bacterium that causes bacterial spots on 
peach seedlings (Civerolo & Keil 1969). However, a significant obstacle in bacteriophage 
treatments has been the actual application. A significant limiting factor has been the 
bacteriophages’ ability to persist on the phyllosphere of plants, or the total above-ground 
portions. Laboratory and field experiments demonstrated that UV-A and UV-B rays were 
the most damaging to bacteriophage populations, but other factors such as rain and pH 
levels also contributed to lowering bacteriophage levels (Ignoffo et al. 1989, Ignoffo & 
Garcia 1992). Plant populations do tend to persist for longer when bacteriophages are 
applied to the rhizosphere (below ground portions of the plant). Bacteriophages stayed 
above detection levels one week after application if the roots were damaged and two 
weeks after application when the roots were healthy (Iriarte et al. 2012).  
Bacteriophages have begun to be used commercially in the USA agriculture and 
food industry. In Baltimore, Intralytix Inc. is a company that sells aqueous bacteriophage 
preparations that target various food-borne illness causing bacteria such as Listeria 
monocytogenes, Escherichia coli, and Salmonella spp. OmniLytics is another company 
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that has pursued research in bacteriophages’ use in agriculture. Their product has been 
developed to control infections of tomato and pepper plants, apple and pear trees, and 
citrus trees. These precedents show the potential use and acceptance of bacteriophage-
based interventions. 
 
Bacteriophages in Insects 
In the field of entomology, bacteriophages have been mostly studied within two 
areas: Wolbachia and aphids, both concerning lysogenic bacteriophages. Wolbachia was 
first described in 1924 by Hertig and Wolbach. Since its discovery, it has been estimated 
that Wolbachia can be found in at least 65% of insect species. Wolbachia has become of 
particular interest due to its ability to induce cytoplasmic incompatibility. Bacteriophage 
particles have been found in Wolbachia’s genome and purified to reveal three prophage 
regions, a small pyocin-like element, wMel WO-A, and wMel WO-B (Wu et al. 2004). 
WO-B has gained particular interest due to its isometric head that contains linear double-
stranded DNA and its ability to form mature virion particles. It is hypothesized that the 
WO-B may play a role in Wolbachia’s famed cytoplasmic incompatibility effect (Fujii et 
al. 2004, Iturbe-Ormaetxe et al. 2005, Sinkins et al. 2005) 
The pea aphid, Acyrthosiphon pisum¸ is preyed upon by the parasitic wasp, 
Aphidius ervi. However, when the pea aphid is inoculated with the bacterial symbiont, 
Hamiltonella defensa, the wasp eggs laid in the pea aphid fail to develop (Oliver et al. 
2003). Unlike Wolbachia, H. defens’s prophage regions have been much better 
characterized. H. defensa’s prophages are referred to APSE. Thus far, three APSE 
variants have been characterized each encoding a different toxin gene; shiga tocin, 
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cytolethal distending toxin, and YD-repeat toxin (Moran et al 2005, Degnan & Moran 
2008). 
However, not all H. defensa infections contain APSE’s and some H. defensa 
infections that do contain an APSE have been found to spontaneously lose that 
bacteriophage infection (Oliver et al. 2009). What has been observed, is that for H. 
defensa to be effective, APSE is required to be present in the bacterial genome (Oliver et 
al. 2009). Recently, it has been found that different strains of APSE have different effect 
on H. defensa’s infection and effect on aphids.  
Recently, termites have also become an area of interest with regards to 
bacteriophages. Termites rely on their microbiota and the obligate nutritional mutualisms 
to assist in digesting plant matter (Bingell 2006). Kurtboke & French (2007) were 
interested in identifying and isolating known, but uncharacterized, gut symbionts of 
Coptotermes lacteus. They used bacteriophages to clear the gut of bacteria that they did 
know were colonizing the gut and were able to then reveal novel actinomycete species. 
Tikhe and Husseneder (2018) sequenced the metavirome of the Coptotermes formosanus 
termite to discover a varied community of known and unknown bacteriophages. 
 
New Potential Uses of Bacteriophages 
As bacteriophages can target specific bacteria, they can be used to affect the 
microbiome of the insect gut to affect vector capacity. In the unique lysogenic life cycle, 
bacteriophages could be used to potentially insert genes into bacteria that either produce 
toxins against pathogens in the microbiome, affect the mosquito’s immune system to 
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lower vector capacity, or affect another part of the system in the spread of vector-borne 
diseases. 
Lytic bacteriophages can target and lyse specific bacteria allowing for potential 
vector control uses to be handled more as a precise scalpel as opposed to the non-specific 
hammer that current insecticides are today. Research using lytic bacteriophages would 
also be able to look further into the purpose and effect of specific members of the 
mosquito’s microbiome. As we learn more and more about how important the community 
of bacteria and other microorganisms are to the health and function of animals, we may 
be able to make useful applications of that knowledge. Already we have seen how some 
bacteria can have a direct effect with the vector capacity of mosquitoes as well as innate 
immune responses. 
Bacteriophages appear to be an intriguing and novel tool to use for a better 
understanding of the mosquito microbiome. We have studied the utility of bacteriophages 
to modulate the mosquito microbiota in ways that will affect its lifecycle. We specifically 
investigated how the development of gnotobiotic mosquito larvae was affected when its 
microbiota was targeted with specific bacteriophages. 
In order to better understand the mosquito microbiome, bacteriophages appear to 
be an intriguing and novel tool to use. We have conducted experiments where we 
investigate how mosquito larvae develop when placed in a gnotobiotic environments 
inoculated with one of three bacteria; Escherichia coli strain W3110, a well characterized 
strain, Enterobacter spp., and Serratia spp., two species isolated from lab-reared 
mosquito midguts. We then used the E. coli targeted bacteriophage T7, sourced from the 
company ATCC. The T7 bacteriophage is a commonly used and well characterized 
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bacteriophage that was discovered in 1945 by Demerec and Fano. Since then, it has been 
used extensively in the molecular biology field due to it encoding its own RNA 
polymerase and its ability to transcribe almost any sequence template with a T7 promoter 





MATERIALS AND METHODS 
Mosquito Rearing 
The Rockefeller strain of Aedes aegypti was reared at 27˚C with 80% humidity 
with a 12-hour light/dark cycle. Larval diet was made by mixing one part fish flakes, one 
part rabbit food, and two parts liver powder together and then grinding the mixture into a 
fine powder. Adult mosquitoes were maintained on a 10% sucrose solution. 
 
Bacterial Cultures 
10 ml of Lysogeny broth (LB) was inoculated with 10µl of bacterial freezer stock 
and was placed in a shaker overnight. Enteroacter spp. and Serratia spp. were all kept at 
30˚C overnight. E. coli W3110 was kept at 37˚C overnight. The E. coli W3110 stock was 
obtained from ATCC (ATCC® 27325™). The Enteroacter spp., Serratia spp., 
Microbacterium spp., and Arthrobacter spp. isolated had been previously isolated from 
dissections of lab reared mosquito midguts.  
Before inoculating the larval breeding water with the bacterial liquid cultures, the 
cultures first had to be washed with Phosphate Buffer Solution (PBS). The PBS was 
made by dissolving prepared PBS tables in deionized (DI) water. The overnight bacterial 
culture was spun down in a centrifuge for ten minutes at 7300 rpm. The supernatant was 
poured off, 10 ml of PBS was added back to the tube, and the cells were resuspended. 





 Three different types of agar plates were used, a standard LB agar plate, a base 
agar plate, and a top agar plate. The LB agar plate was made with 20 g of LB powder and 
15 g of agar all mixed in 1 L of DI water. The solution was then autoclaved and after 
autoclaving, about 10-15ml of molten LB agar was poured into plastic petri dishes. The 
base agar plates were made with 10 g of LB powder and 15 g of agar mixed with 1 L of 
DI water. The solution was then autoclaved and once cooled, 5 ml of 1M CaCl2 was 
added. 10-15 ml of molten base agar was then poured into petri dishes. The top agar 
plates were made with 20 g of LB powder and 3 g of agar mixed with 1 L of DI water. 
The solution was then autoclaved and once cooled, 5 ml of 1M CaCl2 was added. 5 ml of 
molten top agar would then be used to be poured onto of the base agar plates for the 
plaque assay. 
 
Bacteriophage Isolation and Stock 
The bacteriophage T7 was obtained from ATCC (ATCC® BAA-1025-B2™). 
Bacteriophages to target Enteroacter spp. and Serratia spp. were isolated from untreated 
waste water. Pre-treatment waste water samples were obtained from Baltimore Back 
River Wastewater Treatment Plant. 50 ml waste water samples were first centrifuged to 
remove large debris particles and then passed through a 0.2 µm filter (Nalgene™ Rapid-
Flow™ Sterile Disposable Filter Units) in order to remove the bacteria and smaller debris 
in the sample.  
Plaque assays were then conducted. First, the filtered waste water was serially 
diluted in a 50:450µl ratio of waste water and phage buffer. Phage buffer was made by 
mixing and autoclaving 1 ml of 1M MgSO4, 1 ml of 1M TrisCl, and 98 ml of DI water. 
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After cooled from the autoclave, 500 µl of 1M CaCl2 was added and the entire solution 
was filtered through a 0.2 µm filter. 
 50 µl of a serial dilution was mixed with 450 µl of bacteria. A range of dilutions 
was used as the bacteriophage concentration was unknown, typically dilutions of 104, 
106, and 108 were used. The serial dilution mixture was then incubated at either 30˚C or 
37˚C depending on the bacteria used for 20 minutes. After incubation, the serial dilution 
mixture was mixed with 4.5ml of molten top agar and then was poured on a solidified 
base agar plate. These plates were then incubated for 24 hours at the respective 
temperature for the used bacteria. Plugs were taken from plates where clear, individual, 
isolated plaques were formed and then submerged in 1ml of phage buffer. If there were 
too many overlapping plaques and no isolated ones, the process had to be redone using a 
higher dilution. If no plaques formed at all, the process had to be repeated at a lower 
dilution. 
After the plug had been sitting in the phage buffer for approximately 30 minutes, 
the phage buffer mixture was then passed through a 0.2 µm syringe filter and the plaque 
assay was repeated with the filtered phage buffer. This process was repeated a total for 
three times in order to purify a single bacteriophage type. 
The final purified bacteriophage-phage-buffer solution was diluted to the point 
where, after conducting a plaque assay and being set overnight, plaques were too 
numerous and close together to be counted, but not at such a low dilution that the plaques 
covered the plate entirely. These were called web plates and once 10 web plates had been 
made and set overnight, approximately 5ml of phage buffer was used to cover the top of 
the plate. After sitting for approximately 30 min, the phage buffer was poured off and 
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passed through a 0.2 µm filter before being stored at 4°C. Bacteriophage concertation in 
these stocks were measured using plaque assay described earlier. These stocks were 
referred as high titer lysates. 
 
Gnotobiotic Mosquito Assays 
Mosquito eggs were surface sterilized using a 70% ethanol solution and a 3% 
bleach solution as described below. The ethanol solution, bleach solution, and sterile 
water were placed in a 6-well plate. Eggs were held in and moved with a cell strainer that 
fit into the wells. Eggs were submerged in the 70% ethanol solution for 5 minutes and 
then submerged in sterile water for 5 minutes. They were then submerged in the 3% 
bleach solution for 5 minutes and then sterile water for 5 minutes. The eggs were then 
again submerged in the ethanol solution for minutes before being submerged in sterile 
water 3 times, each for 5 minutes.  
Once surface sterilized, the eggs were moved to a 200 ml cell culture flask with 
approximately 80 ml of sterilized water using a sterile cotton swab. The flask was then 
put into a vacuum for approximately 1-2 hours to force the eggs to hatch.  Once hatched, 
5-6 mosquito larvae were allocated into one well in a 6-well plate using a pipet.  
The larval food solution was made at a concentration of 3.3 mg of larval diet per 
100 µl of water and then autoclaved. The larvae were fed 3.3 mg of food on days 1 and 2. 
They were then fed 8.3 mg of food on days 4 and 5. 
After mosquito larvae allocation, 500 µl of direct PBS washed bacterial overnight 
culture was added to each well and 500 µl of PBS was added to controls and sterile water 
was then added to the well until the total volume was at 5 ml. For the Microbacterium 
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spp., and Arthrobacter spp. experiments, 500 μl of direct PBS washed overnight liquid 
bacteria culture was added to one set of treatments. In another set of treatments, the 
washed culture was diluted by 104 through a serial dilution and added 500μl of that 
dilution was inoculated into the larval breeding water. 
Because the mosquitoes must avoid contamination from both the other 
experiments with different bacteria and the bacteria present in the overall lab 
environment, the entirety of the gnotobiotic mosquito assay was performed in a laminar 
flow cabinet. Each unique gnotobiotic mosquito assay was replicated three times.  
 
Single Time Bacteriophage Inoculation 
Approximately 109 bacteria cells were added to the breeding water, which was 
about 500µl of direct PBS washed bacterial overnight culture measured at an OD600 
reading of 1.4, along with approximately 109 of bacteriophage virions, 500 µl of 
bacteirophage high titer lysate, on day one. 100µl of sterile larval food solution was also 
added. For the controls, 500 µl of PBS and 500 µl of phage buffer were added to the 
wells. Sterile water was then added to the well until the total volume was at 5 ml. Once 
all treatments were set up in the 6-well plates, the plates were sealed and moved to an 
incubator where the larval were held in the environment described in the “Mosquito 
Rearing” section 
 
Multiple Time Bacteriophage Inoculation  
Similar to the Single Time Bacteriophage Inoculation protocol above, 109 bacteria 
cells and 109 bacteriophage virions were added to the breeding water (500 µl of direct 
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PBS washed bacterial overnight culture and 500µl of bacteriophage high titer lysate) on 
day one. 100 µl of sterile larval food solution was also added. For the controls, 500 µl of 
PBS and 500 µl of phage buffer were added to the wells. Sterile water was then added to 
the well until the total volume was at 5 ml. 109 bacteriophage virions (500 µl of 
bacteriophage high titer lysate) was then also added on day 2, 4, and 5, the same schedule 




Once high titer lysates had been created, the host range of the isolated 
bacteriophages was tested. To do so, a bacterial agar plate was created. 500 µl of 
overnight bacterial culture was added to 4.5ml of molten top agar and the mixture was 
poured onto a solidified base agar plate and then set at room temperature. As the top agar 
set, bacteriophage serial dilutions were made. The high titer lysates were serial diluted in 
a 50:450 µl ratio of high titer lysate to phage buffer from 101 dilution to 106 dilution. 
Once the bacterial top agar had finished setting, sections were drawn on the plastic dish 
and each section was labeled from 101 to 106 with additional sections for a control and a 
direct sample. 10 µl of each serial dilution was then pipetted onto the top agar along with 
10 µl of phage buffer for a negative control and 10µl of direct high titer lysate. The plates 
were left to set again at room temperature for 30-60 minutes. Afterwards, the plates were 
inverted and placed in a 30˚C or 37˚C incubator overnight. This assay demonstrated 
whether a bacteriophage could infect the bacteria it was tested against and if it does infect 




Culturing Bacterial Colonies and Bacteriophage Plaques 
Each day, 50 µl of water samples were taken from each well to determine the 
Colony Forming Unit (CFU)/ml and the Plaque Forming Unit (PFU)/ml for that well. 
CFU/ml measurements were determined by serial diluting the water samples with PBS at 
a 50:450 µl ratio of water sample to PBS. The dilutions were then plated on LB agar 
plates, typically between the 104, 106, or 108 dilution. 500 µl of the bacteria dilution was 
then mixed with 4.5 ml of top agar and then poured onto base agar plates. The CFU/ml 
plates were then incubated at 30˚C or 37 ˚C overnight depending on the bacteria used. 
PFU/ml measurements were similarly determined by filtering 100 µl of water 
samples through a 0.2 µm filter and then serial diluting those filtered samples at a 
50:450µl ratio of water sample to phage buffer. 50 µl of the serial dilutions were then 
mixed with 450 µl of bacterial overnight stock and incubated at 30˚C or 37˚C for 15 
minutes depending on the bacteria. After incubation, the bacteria and phage solution were 
mixed with 4.5ml of top agar and then poured onto base agar plates. The PFU/ml plates 
were then incubated at 30˚C or 37 ˚C overnight depending on the bacteria used. 
 
Bacteriophage Growth Curves 
300 µl of overnight bacterial culture was added to 30ml of liquid LB. The OD600 
was then immediate taken for a time point of 0. After one-hour, high titer lysate 
bacteriophage was added to the tube. The amount of high titer lysate added to the 30 ml 
of bacterial culture depended on the chosen MOI for the bacteriophage that was being 










A photometer was used to measure the OD600 and the OD600 was checked every 
hour for 6-8 hours. Phage buffer was added to a bacterial culture tube as a control the 
amount of phage buffer added matched the greatest amount of high titer lysate added to a 
treatment. Liquid LB was used as a blank. During the entirety of the growth curve 
experiment, the liquid culture tubes were kept on a shaker held at either 30˚C or 37˚C 
depending on the bacteria. 
 
Bacteriophage Characterization and Genome Sequencing and Annotation 
1 ml of the previously described high titer lysates was transferred to a 15 ml 
conical tube. 12.5 µl of 1 M MgCl2, 0.4 µl of DNAase, and 1 µl of RNAase were then 
mixed into the tube and was left to incubate at room temperate for 30 minutes. 
Afterwards, 40 µl of 0.5 M EDTA, 5 µl of proteinase K, and 50 µl of 10% SDS were 
added in order, the tube was vortexed, and then incubated at 55°C for 60 minutes. During 
the 60-minute-incubation, the tube was vortexed every 20 minutes. After the incubation, 
the mixture was the processed using the standard DNA Phenol:chloroform:isoamyl 
alcohol at 25:24:1 extraction procedure. Once extracted, the DNA was run through on a 
gel electrophoresis to confirm successful extraction and then tested on the Thermo 
Scientific NanoDrop 2000 Spectrometer in order to determine the DNA concentration in 
the sample.  
After extraction, the DNA was sent for sequencing using the Illumina MiSeq 
platform located at the Molecular Research MP in Shallowater, TX. The genomic reads 
were then assembled using the SPADES genome assembler available on the Cyverse 
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platform (http://www.cyverse.org/discovery-environment). Once assembled, the 
bacteriophage genome was analyzed using the GeneMark.hmm with Heuristic models 
gene prediction program using genetic code 11 
(http://exon.gatech.edu/GeneMark/heuristic_gmhmmp.cgi, Besemer & Borodovsky 
1999). Once the gene prediction were obtained, the NCBI BLASTp was used to manually 
annotate the genome for potential and hypothetical proteins. The bacteriophages’ 
genomes were then compared visualized using the Easyfig (Sullivan et al. 2011) platform 
application. 
High titer lysates were also sent to the Johns Hopkins Institute for Basic 
Biomedical Sciences Microscope Facility for bacteriophage visualization. 
 
Statistical Analysis 
 All graphs were created in Microsoft Excel. Two sample t-tests (assuming 
unequal variances) were used to determine statistical differences between time points of 





Effect of the Presence of E. coli, Enterobacter spp., and Serratia spp.  in the Larval 
Breeding Water on Pupation  
In order to evaluate any effects the bacteriophages had on mosquito larvae, we 
first had to create a baseline, by monitoring larval development under gnotobiotic 
conditions without bacteriophage exposure. We selected three bacteria species, E. coli, 
Enterobacter spp., and Serratia spp. for this first round of tests. As seen in Figure 6, the 
E. coli and Enterobacter spp. appeared to influence larvae similarly with regards to 
pupation, development rates and survival. On day six, there was a significant difference 
between the percentage of pupation (p<0.05), however, that difference only lasted for one 
day. The median pupation time upon E. coli exposure was 5.65 days with 97% survival. 
With the Enterobacter spp. treatment, the media pupation time was 6.08 days with 98% 
survival. The Serratia spp. treatment delayed pupation by about two days compared to 
the other two treatments. The media pupation time was 7.88 days and the Serratia spp. 
treatment also resulted in a much lower pupa survival at 77%. There was a significant 
difference between the Serratia spp. treatment and the two other bacteria treatments 
starting on day six (p< 0.05). The larvae in the control wells did not develop and 




Figure 6: Breading water of gnotobiotic A. aegypti larvae were inoculated with E. coli, 
Enterobacter spp., or Serratia spp.. Wells were checked daily for new pupa development 
and were monitored until all living larvae pupated (n=3). Two-sample t-tests were used to 



















Pecentage of Pupation Over Time
Control (No Bacteria) E. coli Enterobacter Serratia
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Effect of Two Microbacterium Species and Arthrobacter spp. on Pupation  
For the second round of pupation tests, we investigated the effect of two different 
Microbacterium species and Arthrobacter spp. when the larval breeding water was 
inoculated with either a direct sample from the overnight bacterial culture or a 104 
dilution. Shown in Figure 7, we can see that Microbacterium 1 (MIB1) was not able to 
recuse larval development and neither the direct nor the diluted inoculations resulted in 
any pupation. Microbacterium 2 (MIB2) stimulated limited pupation and low survival. 
There was no significant difference between the direct or the diluted inoculations. The 
final percent of pupation upon MIB2-D inoculation was 38.9% and for MIB2-E4 it was 
17.6%. Arthrobacter spp. (ARB) appeared to stimulate more standard development to 
pupation as well as increased survival compared to the two Microbacterium species; 
68.8% for the direct inoculation and 81.3% for the dilution inoculation. While there was a 
significant difference between the direct and the diluted inoculations on day seven (p< 
0.05), that difference disappeared by the next day. By day nine, the effects of both 
Arthrobacter spp. treatments were significantly different from that of the Microbacterium 
treatments. The larvae in the sterile control wells did not develop and stayed as first instar 
larvae. 
Though in each replicate, each treatment has three replicate wells, only one full 
replicate has been done with this pupation test. Bacteria colony counts were not 




Figure 7: Breeding water of gnotobiotic A. aegypti larvae were inoculated with one of 
two different Microbacterium species (MIB1, MIB2) or Arthrobacter spp. (ARB). Two 
different concentrations were tested, either a direct inoculation (D, solid line) or an 
inoculation of a 104 (E4, dashed line) dilution. Wells were checked once a day for new 
pupa development and were monitored until all living larvae pupated (n=1). Two-sample 
t-tests were used to assess significant differences between different treatments’ 
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E. coli, Enterobacter spp., and Serratia spp. Load in the Breeding Water   
Bacterial load, measured by colony forming units per ml, were measured from 
water samples at the same time as the pupation measurements upon inoculations with E. 
coli, Enterobacter spp., or Serratia spp.. Only the first seven days of the treatment were 
measured as the majority of larval development occurred in this time period. By day 
seven, there were also some occurrences of emerging adults making it impossible to 
collect water samples. For the E. coli treatment, CFU/ml gradually decreased from 8.74 
log(PFU/ml) on day one to 6.82 log(PFU/ml) on day four, at which the CFU/ml started to 
increase, coming back to 8.86 log(PFU/ml) by day seven (Figure 8). This was unlike 
either the Enterobacter spp., or Serratia spp. measurements. In the Enterobacter spp., 
and Serratia spp. treatments, the CFU/ml levels were more constant as compared to the 
E. coli measurements, with a slight increase in CFU/ml over time. Serratia spp. started at 
6.31 log(PFU/ml) on day one, increased to 8.48 log(PFU/ml) by day three at which point 
increases of CFU/ml greatly slowed down (Figure 8). The Enterobacter spp. bacterial 





Figure 8: Breeding water of gnotobiotic A. aegypti larvae were inoculated with E. coli, 
Enterobacter spp., or Serratia spp. and water samples were taken from each well to 
measure colony forming units per ml (n=3). Two-sample t-tests were used to assess 
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Effect of T7 Bacteriophage-Mediated E. coli Lysis on Pupation 
After establishing the percent pupation over time for the six bacteria, we used the 
T7 bacteriophage treatment to develop a model bacteria-bacteriophage system using E. 
coli. The T7 pupation experiment was carried out just as the other six bacteria-only 
treatments were, but 500µl of high titer bacteriophage lysate was added to the treatment 
wells at the start of the experiment on day one. When the bacteriophage lysate was only 
added on day 1, the median time of pupation in the E. coli+T7 bacteriophage treatment 
was 7.38 days and the percent survival was 81% (Figure 9). Compared to the median 5.65 
days and a 97% survival for the E. coli treatment without bacteriophage, there was a clear 
different between the two treatments. Days six, seven, eight, and nine all had a significant 
difference between the E. coli and E. coli+T7 bacteriophage treatments (p< 0.05).  
When the bacteriophage lysate was added on multiple days, there was a similar 
difference between the E. coli+T7 bacteriophage treatment and the control. As seen in 
Figure 10, as of day 8, the media time of pupation in the E. coli+T7 bacteriophage 
treatment was 5.59 and the percent survival was 90%. In the control, the median was 7 
days and the percent survival was 61%. Due to contamination in the wells, the multiple 




Figure 9: Breeding water of gnotobiotic A. aegypti larvae were inoculated with E. coli. 
One treatment was just inoculated with E. coli on day one, the other was inoculated with 
E. coli along with the T7 phage on day one. Wells were checked daily for new pupa 
development and were monitored until all living larvae pupated (n=3). Two-sample t-



















Pecentage of Pupation Over Time- One Time Inoculation




Figure 10: Breeding water of gnotobiotic A. aegypti larvae were inoculated with E. coli. 
In the E. coli +T7 bacteriophage treatment, bacteriophage was added on days 2, 4, and 5. 
Wells were checked daily for new pupa development and were monitored until all living 
larvae pupated (n=1). Two-sample t-tests were used to assess significant differences 
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Bacterial Load of E. coli in the Presence and Absence of T7 Bacteriophage in the 
Larval Breeding Water 
There was a significant difference between the CFU/ml of the E. coli and E. coli 
+T7 bacteriophage one-time inoculation treatments on days two and three, but after day 
three, the E. coli+T7 bacteriophage treatment followed the E. coli CFU/ml trend and no 
significant differences were observed (Figure 11). The multiple-time inoculation 
treatments do not follow the same pattern as the one-time inoculation treatments. In the 
E. coli +T7 bacteriophage multiple-time inoculation treatment, there is a gradual decrease 
in the log(CFU/ml) from 7.83 on day one to 5.11 on day four. The log(CFU/ml) then 
recovers to 8.42 by day seven. It is in the E. coli control multiple-time inoculation 
treatment that the log(CFU/ml) drops on day two before recovering to similar day one 
levels for days 3, 4, 5, 6, and 7. There is a significant difference between the E. coli and 
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Figure 11: In the one-time bacteriophage inoculation E. coli treatments of the gnotobiotic 
A. aegypti larval breeding water, water samples were taken from each well to measure 
colony forming units per ml (n=3). Two-sample t-tests were used to assess significant 
differences between different treatments’ timepoints (p<0.05). 
 
 
Figure 12: In the multiple-time bacteriophage inoculation E. coli treatments of the 
gnotobiotic A. aegypti larval breeding water, water samples were taken from each well to 
measure colony forming units per ml (n=1). Two-sample t-tests were used to assess 
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Bacteriophage Load of T7 in the Larval Breeding Water 
Bacteriophage PFU/ml were also taken from the water samples of the E. coli+T7 
bacteriophage treatments for the first seven days of the experiment. The drop from 8.85 
log(PFU/ml) on day one to 6.78 log(PFU/ml) mirrors the drop in CFU/ml of the one time 
inoculation E. coli+T7 bacteriophage treatment. The T7 PFU/ml also climbs back up to 
similar levels as day one by the end of the seven days, similar to the pattern in the 
CFU/ml measurements of the treatment (Figure 13). The bacteriophage load of the 
multiple time inoculation treatment was not taken. 
 
 
Figure 13: In both the one-time and multiple-time bacteriophage inoculation E. coli 
treatments of the gnotobiotic A. aegypti larval breeding water, plaque forming units per 
ml were measured from the E. coli+T7 bacteriophage treatments from water samples that 




























observed. Two-sample t-tests were used to assess significant differences between 
different treatments’ timepoints (p<0.05). 
 
Screening of Novel Bacteriophages 
 After establishing the E. coli+T7 bacteriophage model, we began using the 
untreated sewage water from the Baltimore Back River Wastewater Treatment Plant to 
screen for potential bacteriophages that targeted different bacteria strains. The bacteria 
and bacteriophage rich wastewater provide an ideal breed ground for a high density and 
diversity of bacteriophages (Tanji et al. 2008) allowing us to more easily collect 
potentially useful bacteriophages as opposed to using environmental samples. After 
filtering the wastewater, adding it to bacteria, and then preforming plaque assays, we 
were able to isolate eleven bacteriophages targeting Enterobacter spp. and two targeting 
Serratia spp.. However, there was no guarantee that we had isolated unique 
bacteriophages. As bacteriophages were obtained by identifying plaques as described in 
the methods, the only way of immediately identifying potentially different bacteriophages 
was through plaque morphology. Though there was a variety of plaque morphologies 
across the isolation assay, it was not guaranteed that all identified plaques were indeed 
due to unique bacteriophages. Isolating and sequencing the bacteriophage DNA would be 
the only method of confirming if all thirteen isolated bacteriophages were unique or if 





Testing the Host Range of Enterobacter spp. and Serratia spp. Bacteriophages 
The EAP1 and EAP2 bacteriophages were isolated using Enterobacter spp. 
exposed to sewage water filtrate. To ensure that EAP1 and EAP2 only infected 
Enterobacter spp., the two bacteriophages were challenged against five other bacteria 
that had been previously isolated from the mosquito midgut. Neither of the 
bacteriophages were able to infect and develop plaques on the other bacteria challenges 
besides Enterobacter spp. (Table 2). The host range assays for the SAP2 and SAP4 
bacteriophages were established in the same way. SAP2 and SAP4 were isolated using 
Serratia spp. and like EAP1 and EAP2, only infected and created plaques with the 
bacteria they had been isolated from (Table 2).  
  Mosquito Gut Bacteria 










EAP1 O X X X X X 
EAP2 O X X X X X 
SAP2 X X O X X X 
SAP4 X X O X X X 
 
Table 2: Host Range test of isolated bacteriophages. O indicates plaques did appear on 
the host range assay for that bacterial plate. X indicates that plaques did not appear on the 
range assay for that bacterial plate. The bacteria that the bacteriophages were challenged 
against were as follows: Entero- Enterobacter spp., CSPP- Chromobacterium spp., Ser- 
Serratia spp., Asaia- Asaia spp., Elizab- Elizabethkingia spp., Pseud- Pseudomonas spp. 
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Effect of Bacteriophage-Mediated Enterobacter spp. Lysis on Bacteria Load 
Investigating the eleven Enterobacter spp. bacteriophages, we focused on two 
bacteriophages that had the strongest lytic ability, which was based on the morphology of 
the bacteriophage plaques. Bacteriophages that had largest and clearest plaques were 
chosen. Figure 14 shows that when those two bacteriophages tested (EAP1 and EAP2) 
against liquid Enterobacter spp. culture, both significantly lowered the OD600 reading 
compared to the control, indicating that both bacteriophages were able to effectively 
infect and lyse the bacteria (p<0.05). 
 
Figure 14: Enterobacter spp. growth curves depicting the effect of bacteriophage 
addition at an MOI of 10. Bacteriophage was added after the one-hour timepoint was 
taken. Both EAP1 and EAP2 had significantly different OD600 measurements as 
compared to the control by hour four. By hour eight, EAP1 and EAP2 had significantly 
different OD600 readings from the other (n=3). Two-sample t-tests were used to assess 
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Effect of Bacteriophage-mediated Serratia spp. Lysis on Bacteria Load 
Serratia spp. bacteriophages were isolated and then tested in a Serratia spp. liquid 
culture challenge. Despite having developed plaques on a bacterial agar plate, it was clear 
that there was no effect of the bacteriophage on the Serratia spp. liquid culture. Both 
isolated bacteriophages, SAP2 and SAP4 were tested to evaluate their effect on their own 
and they were also combined to test of there might be any interaction between the two 
bacteriophages that would affect their infectiousness. None of the treatments show any 
significant difference from the Serratia spp. control as seen in Figure 15.  
 
 
Figure 15: Serratia spp. growth curves depicting the effect of bacteriophage addition at 
an MOI of 100. Bacteriophage was added after the 1-hour timepoint was taken. There 
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combination of the two bacteriophages and the control. Two-sample t-tests were used to 
assess significant differences between different treatments’ timepoints (p<0.05) (n=3).  
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Effect of T7 Bacteriophage-mediated E. coli Lysis on Bacteria Load 
Across the five tested bacteriophages, T7 shows the most drastic effect when 
inoculated with E. coli. Previous literature demonstrated that T7 was an extremely lytic 
bacteriophage and this data supports that conclusion. As shown in Figure 16, the 
bacteriophage takes immediate effect after it was inoculated into the bacteria liquid 
culture after the one-hour time point. By the two-hour time point, there was already a 
significant difference between the T7 and control treatments (p< 0.05).  
 
 
Figure 16: E. coli growth curve with a E. coli control and a T7 bacteriophage treatment. 
The bacteriophage was added after the one-hour timepoint was taken. By hour two, there 
was a significant difference between the two treatments throughout the assayed time-
period. Two-sample t-tests were used to assess significant differences between different 
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Characterizing Enterobacter Bacteriophages 
After isolating the two Enterobacter spp. bacteriophages, they were sent to be 
sequenced using the Illumina MiSeq platform, and then both bacteriophages were 
assembled and annotated (Supplemental Material 1 and 2). After manually annotating 
both genomes using the NCBI BLASTp database, we were able to see that their genome 
organizations were quite different with a low level of similarity which indicated that they 
are two separate bacteriophages (Figure 17). It was also revealed that EAP1 and EAP2 
were not bacteriophages isolated from the sewage water, but instead prophages that had 
been integrated into the genome of an Enterobacter strain that had emerged upon 
exposure to the sewage water.  
When first isolating bacteriophages from sewage water, the Enterobacter strain 
Esp_Z was used. Esp_Z has been previously sequenced and the sequence is publicly 
available on the NCBI GeneBank database. From there, it was known that there were four 
prophage regions in the genome, two were possibly viable, two were not. Initial attempts 
to stress Esp_Z to induce the lytic cycle of the prophages seemed to fail to induce 
bacteriophage production and it was assumed that all prophage regions were not viable, 
and experiments were carried out assuming that EAP1 and EAP2 were isolated from 
sewage water. However, it is clear that two of the regions were viable and that EAP1 and 
EAP2 had spontaneously induced from those regions.  
Electron microscopy photographs were taken of both bacteriophages and from 
those photographs, both bacteriophages were able to be categorized by family based on 
their morphology. Both bacteriophages had clear elongated necks that are characteristic 




Figure 17: Genetic comparison of EAP1 and EAP2.  
  
Figure 18: Electron microscopy photographs. A) Photograph of EAP1. B) Photograph of 
EAP2. 
 
Table 3: Genetic analysis of EAP1 and EAP2. Summary of the sizes of both 
bacteriophages and other characteristics, the start codon of the tRNA and the 





Mosquitoes have exerted an enormous public health burden on mankind for 
centuries due to their ability to transmit numerous viruses and other human pathogens. In 
order to combat their risk to humans, one of the most effective methods of control has 
been mosquito population control. Insecticides such as pyrethroids and organophosphates 
that target and reduce mosquito populations have been used globally. Pyrethroids, the 
most common adulticides, are used in control methods such as bed nets and indoor 
residual house spraying. They are popular due to their low toxicity in humans and their 
effectiveness in killing insects (Hougard et al. 2002). Organophosphates on the other 
hand are an example of larvicides. Resistance has been detected for both of these 
insecticides, along with the four other classes of insecticides (WHO 2019). 
As resistance spreads, we will need to find new ways to control vector 
populations. The microbiota, being essential for the mosquito lifecycle, could be utilized 
for mosquito population control. However, new tools need to be developed to investigate 
the role of the microbiota, how it effects the mosquito lifecycle and vector competence. 
In this study, we were interested in investigating how bacteriophages could 
modulate the larval breeding water microbiota, and how that could affect larval 
development. We first chose to inoculate sterile mosquito larval breeding water with one 
of six bacteria species, E. coli, Enterobacter spp., Serratia spp., one of two 
Microbacterium species, or Arthrobacter spp.. All the bacterium species except for E. 
coli had been isolated from the lab-reared A. aegypti mosquito microbiota. E. coli was 
chosen in order to have a bacteria species that was fully characterized and that had been 
previously shown to mimic similar larval development as non-sterile environments (Coon 
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et al. 2014). We used the W3110 strain (ATCC). Observing how the larvae developed 
when in the presence of just one bacteria species gave us insight on how different 
bacteria species could induce differences in development. 
Of the six bacteria species, E. coli and Enterobacter spp. showed to have to have 
the fastest pupation rates and the highest survival rates. Larvae in the Serratia spp. and 
Arthrobacter spp. treatment groups took longer to pupate and displayed a lower pupal 
survival (Figure 6 and 7). The two Microbacterium spp. had very low pupation rates if 
the larvae even managed to pupate at all. Microbacterium species 1 was not able to 
rescue the larval development at all, regardless of how much bacteria was added. These 
clear differences between species were able to show that the type of bacteria added to the 
larval breeding water environment does matter. Coon et al. (2017) posited that larval 
development relied on bacteria-mediated hypoxia in the mosquito larval gut. This could 
indicate that the differences observed in larval development between bacteria species 
may indicate that the investigated bacteria species had different levels of oxygen usage 
and aerobic respiration. However, Correa et al. (2018) showed that live bacteria was not 
necessary for development and hypoxia may not be the only reason for continued 
development. Thus, differences in aerobic respiration may not be the only reason for 
differences of development. There may be differences in the proteins that the bacteria use 
or secrete or there may be a difference in how the mosquito immune system reacts to 
each bacteria species that affects development. Further research must be done in order to 
discover the molecular reason for the differences in development. 
The colony forming units per ml (CFU/ml) was measured for the E. coli, 
Enterobacter spp., and Serratia spp. treatment groups over the course of the first seven 
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days of the experiments. The CFU/ml trends between the three species showed no clear 
pattern (Figure 8). In the E. coli treatment group, the CFU/ml decreased during the 
middle of the week before increasing again by day seven. Enterobacter spp. CFU/ml 
seemed to show a slow increase of over the course of the week. The Serratia spp. 
CFU/ml increased in the first two days before leveling off for the remaining time. It was 
unclear how the differences in CFU/ml trends affect the mosquito larvae. What was clear 
was that each of the three bacteria species demonstrate different influence on larval 
development. Not only was there an effect on pupation time and survival, but there was 
likely a difference in the bacteria concentration necessary for larval development. 
After developing baseline larval development profile, we repeated the E. coli 
treatment and added the T7 bacteriophage to it. Addition of the bacteriophage resulted in 
a clear difference in pupation rate between the E. coli treatment and the E. coli+T7 
bacteriophage treatment groups (Figure 9 and 10). With the T7 bacteriophage, pupation 
was delayed for over a day and the survival of the pupa also decreased. There were 
significant differences in the bacterial load (CFU/ml) only on day 2 and 3 (Figure 11) 
between the E. coli treatment and the E. coli+T7 bacteriophage treatment groups. On day 
2, the CFU/ml of the E. coli+T7 bacteriophage treatment decreased significantly, but 
then rebound before falling back into the same trend as the E. coli treatment on day 4. 
The fact that the biggest difference in CFU/ml between the two treatments occurred on 
day 2 may imply that in order to best affect development, the early stages of the mosquito 
larvae should be targeted with phages. While the CFU/ml of the E. coli+T7 
bacteriophage treatment group did recover to a similar level to the E. coli treatment 
group, the pupation rate and survival of the E. coli+T7 bacteriophage treatment group did 
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not. By using the E. coli+T7 bacteriophage system, we were able to demonstrate that 
bacteriophages can be used to affect the larval breeding environment and through that 
larval development.  
However, the CFU/ml pattern in the E. coli+T7 bacteriophage treatment group 
was unexpected; when the T7 bacteriophage was added to the E. coli liquid culture, 
bacterial load not only dramatically decreased, but also stayed consistently low. In the 
gnotobiotic mosquito larvae assay, the CFU/ml decreased by day 2, but then increased 
and stayed at consistent levels afterwards. The discrepancy between the bacterial load in 
the liquid culture versus the larvae assay may be because the liquid cultures were kept on 
a shaker. The continued agitation increased the number of contacts bacteriophages had 
with potential host cells. In the larvae assay, the well plates were kept steady. Without the 
continued agitation, the number of contacts would have gone down. The discrepancy may 
also be due to the presence of the mosquito larvae. The experiment does not make it clear 
whether the larval development delay is due to a change in the breeding water 
environment or due to a change in the microbiome environment. If the bacteriophage is 
not able to persist in the mosquito larval midgut, the midgut, and thus digestive track 
could become a constant output of E. coli that is sufficient to keep the load in the 
breeding water constant. 
Another explanation may be that the E. coli bacterial load did decrease and that 
the colonies observed were other bacteria that may have been introduced during the set 
up or duration of the experiment. While precautions were taken to ensure a complete 
gnotobiotic environment, contamination was still possible. Contamination was only 
determined by morphological identification of colonies. Thus, a bacteria species with 
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similar morphological traits may not have been noticed. Sequencing of the observed 
colonies may be a possibility in the future to confirm bacteria species.  
We screened for bacteriophages that targeted Enterobacter spp. and Serratia spp.. 
After isolating several phages for each bacterium, we tested the effect of two 
bacteriophages, EAP1 and EAP2, against Enterobacter spp. in liquid culture. The two 
bacteriophages were able to drastically decrease the bacterial load as measured by an 
OD600 reading. By four hours, there was a significant difference between the 
bacteriophage treatments and the control. This difference persisted up to eight hours. 
Between EAP1 and EAP2, there was not an observed significant difference of their effect 
on the bacteria liquid culture. We also tested the effect of two more bacteriophages, 
SAP2 and SAP4, against Serratia spp. in liquid culture. These two bacteriophages did not 
have an effect on the bacteria growth, nor was there an affect when the two 
bacteriophages were combined. This indicates that both bacteriophages were in fact 
lysogenic and integrated themselves into the host cell genome. Further bacteriophage 
screening will be necessary in order to isolate other lytic bacteriophages that infect 
Serratia spp.. 
When EAP1 and EAP2 were sequenced, it was discovered that both were not new 
bacteriophages isolated from sewage water, but rather had been prophages, or 
bacteriophages that had been integrated to a host cell genome. When first isolating 
bacteriophages from sewage water, the Enterobacter strain Esp_Z was used. These 
isolated bacteriophages were then tested against a different Enterobacter species and was 
shown to infect that species (Table 2). We were very interested in seeing that these 
prophage regions were able to be spontaneously induce bacteriophage production. 
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Knowing that the Esp_Z genome has two viable prophage regions, makes the Esp_Z 
genome very interesting and generates the question of whether these prophage regions 
have an effect on the bacteria biology and if this then effects the mosquito midgut 
community. Previous research has shown that prophage regions can increase general 
fitness. Wang et al. (2010) found that when nine cryptic prophage regions were removed 
from E. coli K-12, there was a decrease in growth rate, increased sensitivity to antibiotics, 
and was not able to adapt to osmotic stress as well. Pursuing the possibility of developing 
Esp_Z non-prophage mutants and investigating how the Esp_Z prophage regions affect 
their host cell may help further understand the mosquito microbiome. 
Spontaneous prophage induction is also not a well-studied subject; EAP1 and 
EAP2 may be useful in further investigating spontaneous induction itself. The two main 
theories for spontaneous induction is either stochasticity in host cell gene expression or 
the result of a stress-induced response (Nanda et al. 2015); though the mechanics have 
not been thoroughly investigated, there is interest in investigating how spontaneous 
induction affect the bacteria host beyond only lysing the host cell. It has been shown that 
prophages can affect biofilm development which in turn can also affect bacterial 
virulence (Nanda et al. 2015). 
After obtaining the sequence for both bacteriophages, we then annotated both 
genomes. While many of the annotations were only hypothetical proteins, in both EAP1 
and EAP2, there were similarities with APSE bacteriophage proteins (Supplemental 
Material 1 and 2). Considering the importance of the APSE bacteriophage in H. defensa, 
the presence of similar proteins provides information on hypothetical effects and 
influences EAP1 and EAP2 may have on the bacteria host genome. 
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From this study, we have been able to develop a bacteria-bacteriophage model 
using the E. coli+T7 bacteriophage system to study mosquito-bacteria-bacteriophage 
tripartite interactions. Through this system, we have been able to show that 
bacteriophages can affect the larval breeding water microbiota which has an effect on 
larval development.  
 
Future Directions 
The next immediate step would be to investigate an Enterobacter spp.-
bacteriophage system along with a Serratia spp. one. We would then look at treatments 
where the bacteriophage was added to the larval breeding water at different time points. 
While our study did provide evidence that introduced bacteriophages will have the 
greatest effect on first-instar larvae, this may not always be practically possible. Hence, it 
is important to understand how larval development may be affected when bacteriophages 
are added to later stages of larval development.  
We would also be interested in investigating the other bacteriophages that were 
isolated during the bacteriophage isolation assay. Only two of the eleven Enterobacter 
spp. targeting bacteriophages were tested in liquid bacteria culture. One or more of the 
other seven isolated bacteriophages may also show potential in being used in a 
Enterobacter spp.-bacteriophage system. Additionally, we would want to investigate 
other bacteria that have been isolated from the mosquito midgut such as Pseudomonas 
spp., Asaia spp., and Elizabethkingia spp.. All of these bacteria species have been 
previously isolated and thus, additional bacteriophage screening would be required to 
isolate ones that targeted these bacteria.  
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Once several bacteria-bacteriophage systems have been developed, we would 
assess the combined effect of exposing larval breeding water to multiple phages. The 
mosquito microbiome comprises diverse communities of bacteria. In order to better 
model natural conditions, we have future plans to combine two or more bacterial cultures 
and then introduce one or multiple bacteriophages in order to assess how targeting one 
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PROFESSIONAL EXPERIENCE 
Maryland New Directions 
Research Intern      January 2018 – May 2018 • Baltimore, MD 
• Researched current and potential transportation options for those living in Baltimore city through a 
combination of community outreach and communication, on -the-ground fieldwork of the 
transportation system, and online research. 
• Sought partnerships with other community organizations to collaborate to come up with potential 
solutions to obstacles in transportation access  
• Presented a report on the current status, assessments, findings, cost and schedule changes, 
milestones, and project status of public transportation options in Baltimore and possible 
improvements 
 
Chesapeake and Ohio Canal National Historic Park 
Biological Science Intern              August 2016 – March 2017 • Hagerstown, MD 
• Conducted research to study and monitor the insect populations in the shale barrens, an important 
Appalachian habitat, and studied their correlations with temperature, plant populations, and how 
different insect genera influence each other 
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• Assisted with the development of biological study proposals, survey designs, and scopes-of work 
and conduction of biological field investigations involving wildlife species and habitats 
• Participated in various animal and land surveys to create three invasive vegetation and restoration 
plans 
• Assisted with public outreach activities preparing materials and informally responding to requests 
for information.  
• Assisted with organizing and implementing volunteer events within the park. Taught volunteers 
basics in invasive plant identification and proper removal 
 
Teaching Assistant 
The Evolution of Sex (BIOL 1003)                January 2015 – May 2016 • Minneapolis, 
MN 
Ecology (BIOL 3807)                       May – June 2015 • Itasca State 
Park, MN 
Animal Behavior (BIOL 3811)         May – June 2015 • Itasca State Park, MN 
• Developed skills to effectively communicate lessons and ideas to a broad range of students 
• Responsibilities include instructing students through labs, grading assignments, and tutoring 
students through confusing material from the lab 
• Taught relevant skills necessary for field research and biology at Itasca State Park 
 
MicroPort Medical- Shanghai Subsidiary 
Resource and Development Intern    June 2014 – August 2014 • Shanghai, China 
• Read through papers, procedures, and previous research for current projects. Compared current 
procedures to the requirements needed and edited three translated protocols 
• Navigated Chinese language and cultural barriers  
• Worked in a large team to push two protocols into final review 
 
LEADERSHIP AND VOLUNTEER EXPERIENCE 
Johns Hopkins School of Public Health Student Assembly 
Treasurer                                   May 2018 – Present • Baltimore, 
MD 
• Responsible for budget planning and financial recording for the School of Public Health’s Student 
Assembly 
• Head of the Finance Committee and responsible for leading meetings to evaluate student group 
budget applications 
• Negotiated a higher budget for Student Assembly from the Hopkins’ Student Affairs office 
 
Minnesota Public Interest Research Group (MPRIG) 
Co-Chairleader                 October 2012 – May 2015 • Minneapolis, MN 
(https://gopherlink.umn.edu/organization/95)  
• Participated in democratic and governmental processes to push bills through the Minnesota State 
government 
• Developed strong communications skills by engaging with students on campus and larger 
neighborhood community 
• Responsibilities include leading weekly meetings, organizing students to take action on proposed 
issues affecting the community, and working to attain funding and grants for the group 
 
ADDITIONAL SKILLS 
Adobe Photoshop, Dreamweaver, InDesign, and Illustrator • R and STATA • ArcGIS and QGIS • HTML 
and CSS coding • Microsoft Office Suite and Macintosh equivalents • Google Office Suite 
 
